Reuters logo
BRIEF-Rexahn pharmaceuticals receives notice of allowance for a new u.s. Patent covering the use of rx-3117
July 10, 2017 / 1:12 PM / in 5 months

BRIEF-Rexahn pharmaceuticals receives notice of allowance for a new u.s. Patent covering the use of rx-3117

July 10 (Reuters) - Rexahn Pharmaceuticals Inc

* Rexahn pharmaceuticals receives notice of allowance for a new u.s. Patent covering the use of rx-3117

* Rexahn pharmaceuticals - patent expected to be issued within few months from notice of allowance, and is expected to provide protection to 2036 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below